Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015
Anzahl der Publikationen: 21

2022

Janjic, Aleksandar; Wange, Lucas E.; Bagnoli, Johannes W.; Geuder, Johanna; Nguyen, Phong; Richter, Daniel; Vieth, Beate; Vick, Binje; Jeremias, Irmela; Ziegenhain, Christoph; Hellmann, Ines und Enard, Wolfgang (31. März 2022): Prime-seq, efficient and powerful bulk RNA sequencing. In: Genome Biology, Bd. 23 [PDF, 2MB]

Kellner, Markus; Neubeck, Bettina von; Czogalla, Bastian; Feederle, Regina; Vick, Binje; Jeremias, Irmela und Zeidler, Reinhard (2022): A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape. In: Biomedicines, Bd. 10, Nr. 4 [PDF, 5MB]

Zeller, Christina ORCID logoORCID: https://orcid.org/0000-0003-1834-965X; Richter, Daniel ORCID logoORCID: https://orcid.org/0000-0003-1302-9083; Jurinovic, Vindi; Valtierra-Gutiérrez, Ilse A. ORCID logoORCID: https://orcid.org/0000-0003-4128-5914; Jayavelu, Ashok Kumar; Mann, Matthias; Bagnoli, Johannes W. ORCID logoORCID: https://orcid.org/0000-0003-0393-6157; Hellmann, Ines ORCID logoORCID: https://orcid.org/0000-0003-0588-1313; Herold, Tobias ORCID logoORCID: https://orcid.org/0000-0002-9615-9432; Enard, Wolfgang ORCID logoORCID: https://orcid.org/0000-0002-4056-0550; Vick, Binje ORCID logoORCID: https://orcid.org/0000-0003-1956-2778 und Jeremias, Irmela ORCID logoORCID: https://orcid.org/0000-0003-1773-7677 (2022): Adverse stem cell clones within a single patient’s tumor predict clinical outcome in AML patients. In: Journal of Hematology & Oncology, Bd. 15, 25 [PDF, 1MB]

2021

Yankova, Eliza; Blackaby, Wesley; Albertella, Mark; Rak, Justyna; De Braekeleer, Etienne; Tsagkogeorga, Georgia; Pilka, Ewa S.; Aspris, Demetrios; Leggate, Dan; Hendrick, Alan G.; Webster, Natalie A.; Andrews, Byron; Fosbeary, Richard; Guest, Patrick; Irigoyen, Nerea; Eleftheriou, Maria; Gozdecka, Malgorzata; Dias, Joao M. L.; Bannister, Andrew J.; Vick, Binje; Jeremias, Irmela; Vassiliou, George S.; Rausch, Oliver; Tzelepis, Konstantinos und Kouzarides, Tony (2021): Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. In: Nature, Bd. 593, Nr. 7860: S. 597-601

Tahk, Siret; Vick, Binje; Hiller, Björn; Schmitt, Saskia; Marcinek, Anetta; Perini, Enrico D.; Leutbecher, Alexandra; Augsberger, Christian; Reischer, Anna; Tast, Benjamin; Humpe, Andreas; Jeremias, Irmela; Subklewe, Marion; Fenn, Nadja C. und Hopfner, Karl-Peter (2021): SIRP alpha-alpha CD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells. In: Journal of Hematology & Oncology, Bd. 14, Nr. 1, 155

Kempf, Julia M.; Weser, Sabrina; Bartoschek, Michael D.; Metzeler, Klaus H.; Vick, Binje; Herold, Tobias; Voelse, Kerstin; Mattes, Raphael; Scholz, Manuela; Wange, Lucas E.; Festini, Moreno; Ugur, Enes; Roas, Maike; Weigert, Oliver; Bultmann, Sebastian; Leonhardt, Heinrich; Schotta, Gunnar; Hiddemann, Wolfgang; Jeremias, Irmela und Spiekermann, Karsten (2021): Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML. In: Scientific Reports, Bd. 11, Nr. 1, 5838

Augsberger, Christian; Hanel, Gerulf; Xu, Wei; Pulko, Vesna; Hanisch, Lydia Jasmin; Augustin, Angelique; Challier, John; Hunt, Katharina; Vick, Binje; Rovatti, Pier Eduardo; Krupka, Christina; Rothe, Maurine; Schonle, Anne; Sam, Johannes; Lezan, Emmanuelle; Ducret, Axel; Ortiz-Franyuti, Daniela; Walz, Antje-Christine; Benz, Jorg; Bujotzek, Alexander; Lichtenegger, Felix S.; Gassner, Christian; Carpy, Alejandro; Lyamichev, Victor; Patel, Jigar; Konstandin, Nikola; Tunger, Antje; Schmitz, Marc; Bergwelt-Baildon, Michael von; Spiekermann, Karsten; Vago, Luca; Jeremias, Irmela; Marrer-Berger, Estelle; Umana, Pablo; Klein, Christian und Subklewe, Marion (2021): Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody. In: Blood, Bd. 138, Nr. 25: S. 2655-2669

Tahk, Siret; Vick, Binje; Hiller, Björn; Schmitt, Saskia; Marcinek, Anetta; Perini, Enrico D.; Leutbecher, Alexandra; Augsberger, Christian; Reischer, Anna; Tast, Benjamin; Humpe, Andreas; Jeremias, Irmela; Subklewe, Marion; Fenn, Nadja C. und Hopfner, Karl-Peter ORCID logoORCID: https://orcid.org/0000-0002-4528-8357 (2021): SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells. In: Journal of hematology & oncology, Bd. 14, 155 [PDF, 3MB]

2020

Ruzicka, Michael; König, Lars M.; Formisano, Simone; Boehmer, Daniel F. R.; Vick, Binje; Heuer, Eva-M.; Meinl, Hanna; Kocheise, Lorenz; Zeitlhoefler, Marcus; Ahlfeld, Julia; Kobold, Sebastian; Endres, Stefan; Subklewe, Marion; Duewell, Peter; Schnurr, Max; Jeremias, Irmela; Lichtenegger, Felix S. und Rothenfusser, Simon (2020): RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade. In: Leukemia, Bd. 34, Nr. 4: S. 1017-1026

Stief, Sophie M.; Hanneforth, Anna-Li; Weser, Sabrina; Mattes, Raphael; Carlet, Michela; Liu, Wen-Hsin; Bartoschek, Michael D.; Moreno, Helena Dominguez; Oettle, Matthias; Kempf, Julia; Vick, Binje; Ksienzyk, Bianka; Tizazu, Belay; Rothenberg-Thurley, Maja; Quentmeier, Hilmar; Hiddemann, Wolfgang; Vosberg, Sebastian; Greif, Philipp A.; Metzeler, Klaus H.; Schotta, Gunnar; Bultmann, Sebastian; Jeremias, Irmela; Leonhardt, Heinrich und Spiekermann, Karsten (2020): Loss of KDM6A confers drug resistance in acute myeloid leukemia. In: Leukemia, Bd. 34, Nr. 1: S. 50-62

Stenger, Dana; Stief, Tanja A.; Kaeuferle, Theresa; Willier, Semjon; Rataj, Felicitas; Schober, Kilian; Vick, Binje; Lotfi, Ramin; Wagner, Beate; Grünewald, Thomas G. P.; Kobold, Sebastian; Busch, Dirk H.; Jeremias, Irmela; Blaeschke, Franziska und Feuchtinger, Tobias (2020): Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. In: Blood, Bd. 136, Nr. 12: S. 1407-1418

Salik, Basit; Yi, Hangyu; Hassan, Nunki; Santiappillai, Nancy; Vick, Binje; Connerty, Patrick; Duly, Alastair; Trahair, Toby; Woo, Andrew J.; Beck, Dominik; Liu, Tao; Spiekermann, Karsten; Jeremias, Irmela; Wang, Jianlong; Kavallaris, Maria; Haber, Michelle; Norris, Murray D.; Liebermann, Dan A.; D'Andrea, Richard J.; Murriel, Christopher und Wang, Jenny Y. (2020): Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. In: Cancer Cell, Bd. 38, Nr. 2: S. 263-278

Redondo Monte, Enric; Wilding, Anja; Leubolt, Georg; Kerbs, Paul; Bagnoli, Johannes W.; Hartmann, Luise; Hiddemann, Wolfgang; Chen-Wichmann, Linping; Krebs, Stefan; Blum, Helmut; Cusan, Monica; Vick, Binje; Jeremias, Irmela; Enard, Wolfgang; Theurich, Sebastian; Wichmann, Christian und Greif, Philipp A. (2020): ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells. In: Oncogene, Bd. 39: S. 3195-3205 [PDF, 1MB]

2019

Koczian, Fabian; Naglo, Olga; Vomacka, Jan; Vick, Binje; Servatius, Phil; Zisis, Themistoklis; Hettich, Britta; Kazmaier, Uli; Sieber, Stephan A.; Jeremias, Irmela; Zahler, Stefan und Braig, Simone (2019): Targeting the endoplasmic reticulum-mitochondria interface sensitizes leukemia cells to cytostatics. In: Haematologica, Bd. 104, Nr. 3: S. 546-555

Lynch, Jennifer R.; Salik, Basit; Connerty, Patrick; Vick, Binje; Leung, Halina; Pijning, Aster; Jeremias, Irmela; Spiekermann, Karsten; Trahair, Toby; Liu, Tao; Haber, Michelle; Norris, Murray D.; Woo, Andrew J.; Hogg, Philip; Wang, Jianlong und Wang, Jenny Y. (2019): JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis. In: Leukemia, Bd. 33, Nr. 6: S. 1400-1410

Gaiser, Ann-Kathrin; Hafner, Susanne; Schmiech, Michael; Buchele, Berthold; Schafer, Patrick; Arnim, Christine A. von; Calzia, Enrico; Feuring-Buske, Michaela; Buske, Christian; Vick, Binje; Jeremias, Irmela; Syrovets, Tatiana und Simmet, Thomas (2019): Gold Nanoparticles with Selective Antileukemic Activity In Vitro and In Vivo Target Mitochondrial Respiration. In: Advanced Therapeutics, Bd. 2, Nr. 6, UNSP 1800149

2018

Tzelepis, Konstantinos; De Braekeleer, Etienne; Aspris, Demetrios; Barbieri, Isaia; Vijayabaskar, M. S.; Liu, Wen-Hsin; Gozdecka, Malgorzata; Metzakopian, Emmanouil; Toop, Hamish D.; Dudek, Monika; Robson, Samuel C.; Hermida-Prado, Francisco; Yang, Yu Hsuen; Babaei-Jadidi, Roya; Garyfallos, Dimitrios A.; Ponstingl, Hannes; Dias, Joao M. L.; Gallipoli, Paolo; Seiler, Michael; Buonamici, Silvia; Vick, Binje; Bannister, Andrew J.; Rad, Roland; Prinjha, Rab K.; Marioni, John C.; Huntly, Brian; Batson, Jennifer; Morris, Jonathan C.; Pina, Cristina; Bradley, Allan; Jeremias, Irmela; Bates, David O.; Yusa, Kosuke; Kouzarides, Tony und Vassiliou, George S. (2018): SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4. In: Nature Communications, Bd. 9, 5378 [PDF, 2MB]

2017

Göllner, Stefanie; öllerich, Thomas; Agrawal-Singh, Shuchi; Schenk, Tino; Klein, Hans-Ulrich; Rohde, Christian; Pabst, Caroline; Sauer, Tim; Lerdrup, Mads; Tavor, Sigal; Stölzel, Friedrich; Herold, Sylvia; Ehninger, Gerhard; Köhler, Gabriele; Pan, Kuan-Ting; Urlaub, Henning; Serve, Hubert; Dugas, Martin; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela; Berdel, Wolfgang E.; Hansen, Klaus; Zelent, Arthur; Wickenhauser, Claudia; Müller, Lutz P.; Thiede, Christian und Müller-Tidow, Carsten (2017): Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia. In: Nature Medicine, Bd. 23, Nr. 1: S. 69-78

Kläger, Susan; Heinzlmeir, Stephanie; Wilhelm, Mathias; Polzer, Harald; Vick, Binje; König, Paul-Albert; Reinecke, Maria; Ruprecht, Benjamin; Petzoldt, Svenja; Meng, Chen; Zecha, Jana; Reiter, Katrin; Qiao, Huichao; Helm, Dominic; Koch, Heiner; Schoof, Melanie; Canevari, Giulia; Casale, Elena; Depaolini, Stefania Re; Feuchtinger, Annette; Wu, Zhixiang; Schmidt, Tobias; Rückert, Lars; Becker, Wilhelm; Hünges, Jan; Garz, Anne-Kathrin; Gohlke, Björn-Oliver; Zolg, Daniel Paul; Kayser, Gian; Vooder, Tonu; Preissner, Robert; Hahne, Hannes; Tonisson, Neeme; Kramer, Karl; Götze, Katharina; Bassermann, Florian; Schlegl, Judith; Ehrlich, Hans-Christian; Aiche, Stephan; Walch, Axel; Greif, Philipp A.; Schneider, Sabine; Felder, Eduard Rudolf; Ruland, Jürgen; Medard, Guillaume; Jeremias, Irmela; Spiekermann, Karsten und Kuster, Bernhard (2017): The target landscape of clinical kinase drugs. In: Science, Bd. 358, Nr. 6367, eaan4368

2016

Krupka, Christina; Kufer, Peter; Kischel, Roman; Zugmaier, Gerhard; Köhnke, Thomas; Lichtenegger, Felix; Altmann, Torben; Spiekermann, Karsten; Vick, Binje; Jeremias, Irmela; Hiddemann, Wolfgang; Riethmüller, Gert und Subklewe, Marion (2016): Characterization of covariables modulating CD33/CD3 BITE antibody construct mediated cytotoxicity against primary AML cells. In: Cancer Immunology Research, Bd. 4, Nr. 1

2015

Vick, Binje; Rothenberg, Maja; Sandhöfer, Nadine; Carlet, Michela; Finkenzeller, Cornelia; Krupka, Christina; Grunert, Michaela; Trumpp, Andreas; Corbacioglu, Selim; Ebinger, Martin; André, Maya C.; Hiddemann, Wolfgang; Schneider, Stephanie; Subklewe, Marion; Metzeler, Klaus H.; Spiekermann, Karsten und Jeremias, Irmela (2015): An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging.
In: PLOS ONE 10(3), e0120925 [PDF, 3MB]

Diese Liste wurde am Sat Mar 23 23:21:16 2024 CET erstellt.